Russo Partners
Advertising Networks · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 W 27th St Fl 4, New York City, New Yo...Phone Number
(212) 845-4200Website
www.russopartnersllc.comRevenue
$24.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Russo Partners
The Sports-Health Alliance is an award-winning public relations service at the intersection of health, medicine and sports. Launched by Russo Partners in 2017, this offering leverages the agency's inside access to athletes, broadcasters and sports business leaders who have a shared passion with their clients for a disease or treatment. The Alliance was cultivated over a two-year span and involves Russo Partners' Team Leader Solomon Wilcots.Explore more
Russo Partners Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Russo Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Russo Partners recently announced quarterly report
Check if Russo Partners has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Russo Partners launches new products
Funding: Get notified immidiatlly once Russo Partners has new funding data
Check out if Russo Partners is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Russo Partners
Website visits: Recent activity has been detected on your website
Click to see if Russo Partners had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Russo Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Russo Partners as Masked Content
Find 2 more new buyers
Compare Similar Companies to Russo Partners
Compare insights from companies similar to Russo Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Russo Partners is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Russo Partners is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Russo Partners.
Russo Partners financials insights
Gather financial insights about Russo Partners, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Russo Partners Tech Stack
A closer look at the technologies used by Russo Partners
See more technologies
Russo Partners News & Media
Russo Partners Names Max Jacobs, CFA, as Head of Investor Relations Group
Jacobs Brings More than 20 Years of Diverse Global Experience Across Investor Relations, Investment Research, Communications, Portfolio Management and Market Research in the Healthcare and Biotechnology Fields NEW YORK, May 24, 2022 /PRNewswire/ -- Russo Partners LLC, a public and...Tolero Pharmaceuticals Presents Clinical Data of AXL Kinase Inhibitor TP-0903 Showing its Ability to Enhance Host Immune Responses to Tumors
SALT LAKE CITY, Nov. 15, 2018 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced the presentation of clinical and preclinical data supporting the development of TP-0903 ...SpinalCyte Announces Sustained 12-Month MRI Outcomes After CybroCell™ Injection
HOUSTON--(BUSINESS WIRE)--#celltherapy--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced that a single injection of modified human dermal fibroblasts (HDFs), resulted in significant improvements of disc height and pain reduction 12 months after injection of the cell therapy for patients with degenerative disc disease (DDD). The trial assessed patients using the Oswestry DisabFSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint
TORONTO--(BUSINESS WIRE)--#FSDDF--FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE:HUGE) (OTCQB:FSDDF) (FRA:0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) has been migrated to the Cannabis Act and its regulations, effective November 8, 2018. The issuance of the new cannabis license includes the ability to sell cannabis to other licensed producers in accordance with subs
Read more news
Top Advertising Networks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Russo Partners
Sign Up For FreeTo access detailed company insights
The Sports-Health Alliance is an award-winning public relations service at the intersection of health, medicine and sports. Launched by Russo Partners in 2017, this offering leverages the agency's inside access to athletes, broadcasters and sports business leaders who have a shared passion with their clients for a disease or treatment. The Alliance... Read More
